Medical Science Liaison Germany W​/M

Select how often (in days) to receive an alert:

Department:
Medical Affairs (MED AFFAIRS)

Category:
Medical - Med Affairs

Location:

Germany Field

SERB is a fast-growing global specialty pharma company designed to address rare and urgent conditions by delivering life-saving medicines when time and complexity leave no room for failure.

We operate end-to-end across 100+ countries, ensuring 70+ essential medicines for rare diseases, emergency care, and medical countermeasures reach patients and clinicians with urgency – wherever and whenever they are needed.

Shaped over the past 25 years by an entrepreneurial, disruptive spirit, SERB combines the focus and agility of a biotech with the scale, reach, and reliability of a global pharmaceutical company — always grounded in medical purpose, not corporate convention.

Our 600+ employees are driven by three core values:

• Patients first, always
  Patients are not a concept — they are why we act, especially when time matters most.
• Impact focused
  We are agile, entrepreneurial, and disciplined - working smart and learning continuously to deliver results that matter, with the consistency, quality, and trust that critical care demands.
• Team powered
  We go the extra mile - together - because our shared commitment drives extraordinary outcomes.

Guided by a clear ambition and a relentless focus on patients, SERB continues to expand through selective, innovative acquisitions, launching new treatments and entering new geographies. Across every step — from integration to delivery — our people act with passion, ownership, and determination to ensure life-saving medicines become available to patients who need them, worldwide.

The medical Science Liaison is responsible for supporting the safe and effective use of Company therapies focusing on communication complex medical and scientific information to healthcare professionals and communication field medical intelligence/insights to internlal stakeholders. The MSL has internal and external training responsible for Company therapies. Reporting to the Europe MSL Director, the MSL has an assigned territory autonomously managing, developing and growing medical activities/initiatives achieving key medical objectives by supporting activities of Serb in Germany.

Therapy training to guide the safe and effective use of the Company’s therapies

Proactively engage HCPs providing on‑label product and procedural training of Company therapies.

As a subject matter expert, teach medical education and internal training courses.

Provide product and disease‑state educational/training support to the Company Commercial and R&D departments related to technical, medical and scientific information.

Provide refresher training to users who are not achieving desired outcomes.

Medical support: focus on therapies

• Build, maintain and manage effective professional peer‑to‑peer relationships with contracted external experts (EE) or Key Opinion Leaders engaging in bi‑directional scientific/educational exchange.
• Understand medical/scientific barriers that may influence patient outcomes.
• Focus on ongoing research, newly published evidence, practice pattern changes and alternative therapies.
• Teach the clinical evidence story linking the totality of evidence in a non‑biased manner.
• Inform HCPs about clinical evidence and accurately communicate key evidence gaps.
• Execute on medical plans, communicating technical and clinical data supporting new products and/or new indications.
• Create a territory plan to identify KOLs that will provide meaningful clinical insights.
• Provide medical and scientific support for EEs speaking on Company products at medical meetings and congresses.
• Investigate and gather field medical intelligence/insights that might affect therapy safety/efficacy, Clinical/R&D strategies and competitive activities.
• Create strategies to gain insights from a diverse set of stakeholders.
• Communicates knowledge in a simple, coherent and informative manner to internal stakeholders.
• Identify clinical insights and knowledge gaps and be able to articulate the impact and magnitude of…